The Food and Drug Administration today revoked its emergency use authorization for the Curative SARS-Cov-2 Assay test because the manufacturer has transitioned to using other authorized tests for testing offered at its laboratories. 

Related News Articles

Headline
The Food and Drug Administration today granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old.…
Headline
The Food and Drug Administration today authorized state-licensed pharmacists to prescribe Paxlovid (nirmatrelvir and ritonavir) to patients as a treatment…
Blog
Understanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping…
Headline
An initial 10 million doses of COVID-19 vaccine are available for children under age 5 if the Food and Drug Administration authorizes and the Centers for…
Headline
The Centers for Disease Control and Prevention yesterday broadened its masking guidance, enabling visitors of health care facilities to wear N95 masks.…
Headline
Pfizer yesterday asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 65 and older who…